Immix Biopharma, Inc. Quarterly Operating Lease, Liability in USD from Q1 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Immix Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2024 to Q2 2025.
  • Immix Biopharma, Inc. Operating Lease, Liability for the quarter ending June 30, 2025 was $1.04M, a 4.43% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $1.04M -$48.4K -4.43% Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $1.06M -$34.3K -3.14% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $1.07M Dec 31, 2024 10-Q 2025-08-08
Q3 2024 $1.09M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.09M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.09M Mar 31, 2024 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.